Home › Funds › China Universal Asset Management Co., Ltd. › VRTX

China Universal Asset Management Co., Ltd. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

China Universal Asset Management Co., Ltd. reported holding 51,810 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$27.3M, representing 1.42% of its reported portfolio and ranking #15 among its reported holdings. China Universal Asset Management Co., Ltd. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)51.81K sh
Reported value held$27.29M
Portfolio Weight1.42%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How China Universal Asset Management Co., Ltd.'s VRTX position evolved

China Universal Asset Management Co., Ltd. first disclosed a stake in VRTX in Q3 2023 at 21,168 shares (US$7.4M). The position peaked in Q3 2026 at 51,810 shares, worth US$27.3M. Across 13 filings, China Universal Asset Management Co., Ltd. increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 51,810 shares valued at US$27.3M — an increase of 3,545 shares quarter over quarter.. Notable position changes include a 80% increase in Q4 2023 (shares rose 2% over the following quarter), a 34% increase in Q1 2024 (shares rose 12% over the following quarter), a 42% increase in Q3 2024 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 21.17K $7.36M New
Q4 2023 38.09K $15.50M Add
Q1 2024 51.07K $21.35M Add
Q2 2024 34.85K $16.34M Reduce
Q3 2024 49.42K $22.98M Add
Q4 2024 52.38K $21.09M Add
Q1 2025 48.87K $23.69M Reduce
Q2 2025 44.27K $19.71M Reduce
Q3 2025 45.11K $17.67M Add
Q4 2025 48.05K $21.78M Add
Q1 2026 43.90K $19.60M Reduce
Q2 2026 48.27K $23.97M Add
Q3 2026 51.81K $27.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has China Universal Asset Management Co., Ltd. held VRTX?

China Universal Asset Management Co., Ltd. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is China Universal Asset Management Co., Ltd.'s current position in VRTX?

As of Q3 2026, China Universal Asset Management Co., Ltd. holds 51.81K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $27.29M, representing 1.42% of its reported portfolio and ranking #15.

Has China Universal Asset Management Co., Ltd. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), China Universal Asset Management Co., Ltd. increased its position in VRTX. The position peaked in Q3 2026 at 51.81K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.